With the exception of one seller, Boston Scientific (BSX) continues to attract insider buying. The lone seller is
Nancy Ann Deparle, who was a Director at Guidant, was also a senior adviser to JP Morgan Partners. My best guess here is that her services are no longer needed, especially in light of the merger between GDT and BSX.

Today, we see that Director Nick Nicholas has increased his appetite for BSX shares as he added another 10,000 at $21.39. This brings Nicks total up to 40,000 shares purchased in the open market.

In addition, Mr. Nick brought someone else along for the ride as another Director, Ernest Mario bought 50,000 shares of BSX at $21.35.

As the old saying goes, insiders will sell for a variety of reasons, but they usually only buy for one.